Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Breath Biomarkers for Sleep Loss and Circadian Timing

NCT03980340 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT03980340
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03980340 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Breath Biomarkers for Sleep Loss and Circadian Timing
Lead sponsor
Brigham and Women's Hospital
Phase
Observational
Overall status
Terminated
Start date
January 28, 2021
Completion date
March 31, 2025
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced sleep phase, advanced sleep phase syndrome, advanced sleep phase syndrome (asps), delayed sleep phase, delayed sleep phase syndrome, irregular sleep-wake syndrome, non-24 hour sleep-wake disorder, shift work type circadian rhythm sleep disorder, shift-work sleep disorder, sleep disorders, circadian rhythm, sleep disorders, intrinsic